Published in Medical Letter on the CDC and FDA, July 25th, 2004
The results were presented by Richard Piekarz, MD, PhD, of the NCI, in a poster session entitled "Update on The Phase II Trial and Correlative Studies of Depsipeptide in Patients with Cutaneous T-Cell Lymphoma (CTCL) and Relapsed Peripheral T-Cell Lymphoma (PTCL)," at the recent annual meeting of the American Society of Clinical Oncology in New Orleans, Louisiana.
The phase II study is being sponsored by the NCI...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA